| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
GENB
Generate Biomedicines, Inc.
|
Jun 15, 2026 | BUY |
Strong Buy
+76.8% avg upside
6 analysts
|
$30.00
107.00% Upside
|
· |
|
MBX
MBX Biosciences, Inc.
|
Jun 15, 2026 | BUY |
Strong Buy
+54.0% avg upside
14 analysts
|
$88.00
104.53% Upside
|
+2.9% |
|
RYTM
Rhythm Pharmaceuticals
|
Jun 15, 2026 | BUY |
Strong Buy
+25.2% avg upside
19 analysts
|
$143.00
47.71% Upside
|
+6.8% |
|
SEPN
Septerna, Inc.
|
Jun 11, 2026 | BUY |
Strong Buy
+18.2% avg upside
12 analysts
|
$52.00
43.70% Upside
|
· |
|
BMY
Bristol-Myers Squibb
|
Jun 05, 2026 | BUY |
Buy
+9.1% avg upside
42 analysts
|
$72.00
33.36% Upside
|
-3.5% |
|
GB:AZN
AstraZeneca
|
Jun 03, 2026 | BUY |
Strong Buy
+11.9% avg upside
26 analysts
|
$16500.00
23.91% Upside
|
· |
|
PCVX
Vaxcyte
|
Jun 03, 2026 | BUY |
Strong Buy
+96.3% avg upside
15 analysts
|
$116.00
125.51% Upside
|
+5.0% |
|
IVA
Inventiva
|
May 27, 2026 | BUY |
Strong Buy
+350.1% avg upside
16 analysts
|
$11.00
208.07% Upside
|
-30.6% |
|
ARQT
Arcutis Biotherapeutics
|
May 26, 2026 | BUY |
Strong Buy
+49.8% avg upside
14 analysts
|
$35.00
33.61% Upside
|
+21.6% |
|
MLYS
Mineralys Therapeutics, Inc.
|
May 18, 2026 | BUY |
Strong Buy
+82.2% avg upside
12 analysts
|
$48.00
94.95% Upside
|
-4.8% |
|
ARCT
Arcturus Therapeutics
|
May 11, 2026 | HOLD |
Buy
+291.8% avg upside
35 analysts
|
— | · |
|
AMLX
Amylyx Pharmaceuticals Inc
|
May 11, 2026 | BUY |
Strong Buy
+46.8% avg upside
13 analysts
|
$30.00
91.36% Upside
|
+3.3% |
|
ACRS
Aclaris Therapeutics
|
May 11, 2026 | BUY |
Strong Buy
+122.9% avg upside
15 analysts
|
$12.00
166.66% Upside
|
-12.7% |
|
GPCR
Structure Therapeutics, Inc. Sponsored ADR
|
May 07, 2026 | BUY |
Strong Buy
+132.5% avg upside
17 analysts
|
$140.00
214.58% Upside
|
-6.6% |
|
LLY
Eli Lilly & Co
|
May 05, 2026 | BUY |
Strong Buy
-10.5% avg upside
47 analysts
|
$1235.00
12.34% Upside
|
+11.3% |
|
SGMT
Sagimet Biosciences, Inc. Class A
|
Apr 29, 2026 | BUY |
Strong Buy
+317.2% avg upside
15 analysts
|
$25.00
274.18% Upside
|
-19.8% |
|
APGE
Apogee Therapeutics
|
Mar 30, 2026 | BUY |
Strong Buy
+28.7% avg upside
19 analysts
|
$160.00
77.08% Upside
|
+12.3% |
|
TENX
Tenax Therapeutics
|
Mar 16, 2026 | BUY |
Strong Buy
+213.9% avg upside
8 analysts
|
$34.00
183.27% Upside
|
-11.6% |
|
SNY
Sanofi
|
Dec 09, 2025 | HOLD |
Strong Buy
+74.9% avg upside
20 analysts
|
— | -2.4% |
|
FR:SAN
Sanofi
|
Oct 08, 2025 | BUY |
Strong Buy
+33.0% avg upside
30 analysts
|
$101.00
34.77% Upside
|
· |
|
NVO
Novo Nordisk
|
Apr 17, 2025 | HOLD |
Buy
+168.1% avg upside
26 analysts
|
— | -26.9% |
|
ALT
Altimmune
|
Apr 03, 2025 | HOLD |
Strong Buy
+935.8% avg upside
19 analysts
|
— | -25.1% |
|
GB:0QIU
Novo Nordisk
|
Jan 17, 2025 | BUY |
Hold
+45.6% avg upside
28 analysts
|
$798.00
185.11% Upside
|
· |
|
GB:GSK
GlaxoSmithKline
|
Oct 31, 2024 | HOLD |
Hold
-3.3% avg upside
25 analysts
|
— | · |
|
GSK
GlaxoSmithKline
|
Oct 31, 2024 | HOLD |
Hold
-14.1% avg upside
19 analysts
|
— | +33.3% |
|
MRK
Merck & Company
|
Jan 29, 2024 | BUY |
Strong Buy
+10.7% avg upside
43 analysts
|
$130.00
14.19% Upside
|
-17.3% |
|
ZLAB
Zai Lab
|
Oct 14, 2022 | BUY |
Strong Buy
+223.0% avg upside
13 analysts
|
$83.00
356.64% Upside
|
-12.2% |
|
IVVD
Invivyd
|
Dec 15, 2021 | HOLD |
Buy
+734.3% avg upside
8 analysts
|
— | -74.7% |
|
DE:MRK
Merck KGaA
|
Dec 07, 2021 | HOLD |
Buy
+2.1% avg upside
32 analysts
|
— | · |
|
CH:NOVN
Novartis AG
|
Feb 25, 2020 | HOLD |
Buy
-10.2% avg upside
30 analysts
|
— | · |
|
NVS
Novartis
|
Oct 08, 2018 | HOLD |
Hold
-7.8% avg upside
24 analysts
|
— | +15.3% |
|
ARDX
Ardelyx
|
Oct 17, 2017 | BUY |
Strong Buy
+124.7% avg upside
21 analysts
|
$13.00
114.90% Upside
|
-28.5% |
|
PFE
Pfizer
|
Sep 08, 2016 | HOLD |
Buy
+34.1% avg upside
45 analysts
|
$37.00
46.84% Upside
|
+2.2% |
|
NPKI
NPK International
|
Aug 24, 2016 | BUY |
Buy
+58.6% avg upside
12 analysts
|
$108.00
579.23% Upside
|
-0.8% |
|
KYNB
Kyntra Bio
|
Aug 09, 2016 | BUY |
Buy
+369.6% avg upside
14 analysts
|
$52.00
676.13% Upside
|
+127.5% |
|
ALNY
Alnylam Pharma
|
Jul 15, 2016 | BUY |
Strong Buy
+23.4% avg upside
51 analysts
|
— | +22.1% |
|
REGN
Regeneron
|
Jul 15, 2016 | BUY |
Strong Buy
+26.9% avg upside
57 analysts
|
— | +35.1% |
|
AMGN
Amgen
|
Jul 15, 2016 | HOLD |
Buy
-11.6% avg upside
57 analysts
|
— | +11.4% |
|
JNJ
Johnson & Johnson
|
Jun 14, 2016 | BUY |
Strong Buy
-3.6% avg upside
36 analysts
|
$125.00
45.19% Downside
|
+16.4% |
|
AGIO
Agios Pharma
|
Jun 13, 2016 | HOLD |
Strong Buy
+73.8% avg upside
29 analysts
|
$56.00
64.03% Upside
|
-2.4% |
|
CLDX
Celldex
|
Mar 07, 2016 | HOLD |
Strong Buy
+20.6% avg upside
28 analysts
|
$4.00
87.59% Downside
|
-8.7% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.